[Tree] Establishment of a drug-approval agency in Hong Kong

Version 0.09 (2024-09-08 20:38:33.769000)

updates: Added details on new drug-approval agency and its implications

  • ➔
  • ➔
Version 0.08 (2024-08-11 09:08:27.380000)

updates: Hong Kong's strategic positioning as 'three centres and one hub'

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.07 (2024-07-14 23:59:50.974000)

updates: The Chinese University of Hong Kong plans to open academic centres in Guangdong to boost medical research

  • ➔
  • ➔
  • ➔
  • ➔
Version 0.06 (2024-05-29 06:09:16.726000)

updates: Hong Kong Baptist University and Agilent (China) establish joint lab for research on new pollutants and toxicology

  • ➔
  • ➔
  • ➔
Version 0.05 (2024-05-27 00:52:59.235000)

updates: Integration of Hong Kong biotech innovation at US biotech event

  • ➔
  • ➔
Version 0.04 (2023-10-23 18:35:00.621000)

updates: The narrative now focuses on the webinar series hosted by Hogan Lovells and the specific topics discussed by the panelists.

  • ➔
Version 0.03 (2023-10-22 18:21:59.538000)

updates: Expanded details and added perspectives on investment opportunities

  • ➔
Version 0.02 (2023-10-21 08:08:14.715000)

updates: Expansion of the Belt and Road Initiative in Africa

  • ➔
Version 0.01 (2023-10-21 07:10:57.236000)

updates: The new narrative provides a comprehensive overview of the Belt and Road Initiative, including Chinese President Xi Jinping's reaffirmation of commitment, challenges faced, and the need for changes in approach. It also highlights the presence of Russian President Vladimir Putin and a Taliban delegation at the BRI forum, showcasing China's alternative to the US-led global order.

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.0 (2023-10-20 18:16:48.687000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔